Vital Chemtech Ltd
Incorporated in 2014, Vital Chemtech Ltd manufactures and supplies phosphorous based chemicals[1]
- Market Cap ₹ 135 Cr.
- Current Price ₹ 56.2
- High / Low ₹ 71.6 / 35.4
- Stock P/E 15.0
- Book Value ₹ 47.0
- Dividend Yield 0.00 %
- ROCE 10.8 %
- ROE 8.67 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 1.20 times its book value
- Company's working capital requirements have reduced from 77.2 days to 46.4 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Company has a low return on equity of 6.04% over last 3 years.
- Earnings include an other income of Rs.8.56 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 5m | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 41 | 47 | 58 | 117 | 102 | 120 | 105 | |
| 37 | 41 | 46 | 102 | 97 | 113 | 100 | |
| Operating Profit | 4 | 6 | 12 | 15 | 5 | 8 | 6 |
| OPM % | 10% | 14% | 20% | 13% | 5% | 6% | 5% |
| 0 | 0 | 0 | 0 | 3 | 2 | 9 | |
| Interest | 1 | 1 | 0 | 1 | 1 | 1 | 2 |
| Depreciation | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Profit before tax | 2 | 5 | 11 | 11 | 5 | 7 | 10 |
| Tax % | 55% | 38% | 26% | 30% | 18% | 31% | 14% |
| 1 | 3 | 8 | 8 | 4 | 5 | 9 | |
| EPS in Rs | 11.75 | 3.36 | 1.68 | 1.93 | 3.74 | ||
| Dividend Payout % | 0% | 0% | 0% | 15% | 30% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | -3% |
| TTM: | -12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 25% |
| 3 Years: | 4% |
| TTM: | 93% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -21% |
| 1 Year: | -13% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 6% |
| Last Year: | 9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 24 | 24 | 24 | 24 | ||
| Reserves | 8 | 66 | 66 | 70 | 89 | ||
| 36 | 24 | 13 | 4 | 11 | |||
| 30 | 17 | 24 | 29 | 43 | |||
| Total Liabilities | 81 | 131 | 126 | 127 | 167 | ||
| 17 | 19 | 19 | 19 | 22 | |||
| CWIP | 0 | 0 | 0 | 2 | 0 | ||
| Investments | 3 | 15 | 34 | 22 | 24 | ||
| 61 | 96 | 73 | 84 | 121 | |||
| Total Assets | 81 | 131 | 126 | 127 | 167 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| -13 | -10 | 15 | 9 | 7 | |||
| 1 | -20 | -28 | 1 | -21 | |||
| 18 | 53 | -16 | -10 | 15 | |||
| Net Cash Flow | 6 | 23 | -29 | 0 | -0 | ||
| Free Cash Flow | -22 | -14 | 13 | 5 | 4 | ||
| CFO/OP | -91% | -50% | 332% | 137% | 143% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 264 | 120 | 156 | 131 | 115 | ||
| Inventory Days | 87 | 57 | 59 | 38 | 100 | ||
| Days Payable | 265 | 57 | 106 | 96 | 171 | ||
| Cash Conversion Cycle | 87 | 120 | 109 | 73 | 44 | ||
| Working Capital Days | 59 | 128 | 98 | 87 | 46 | ||
| ROCE % | 15% | 5% | 8% | 11% |
Insights
In beta| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Cumulative Manufacturing Capacity MT |
|
|||||||
| Total Plot Size for Facilities Sq. Mt. |
||||||||
| Number of Key Phosphorus Derivative Products Units |
||||||||
| Number of Permanent Employees Count |
||||||||
Extracted by Screener AI
Documents
Announcements
-
Disclosure under SEBI Takeover Regulations
5 June 2026 - Promoter Vipul Bhatt confirms no share encumbrance by Vital Chemtech promoters in FY 2025-26.
-
General Updates
5 June 2026 - Subsidiary Vital Synthesis received GPCB provisional consent valid till 26/03/2031.
-
Disclosure under SEBI Takeover Regulations
3 June 2026 - Promoter Vipul Bhatt declares no additional encumbrance on Vital Chemtech shares during FY 2025-26.
-
Press Release
1 June 2026 - Vital Chemtech reported Q4FY26 revenue ₹35.1 crore, PAT ₹0.8 crore; FY26 revenue ₹126.4 crore, PAT ₹1.0 crore.
-
Copy of Newspaper Publication
30 May 2026 - Vital Chemtech published audited Q4 and FY2026 standalone and consolidated results on May 30, 2026.
Business Overview:[1][2]
VCL is a part of Vital Group which is a multi-product organization involved in Manufacturing, Contract Manufacturing and Exports of Chemicals. Company does manufacturing and supplying of Phosphorus Derivatives Products and Phosphorus base chemicals. It also does trading of its raw Material and is in the process of obtaining approval of Phosphorus Pentasulfide (P2S5)